EODData

SHG, 605116: Aurisco Pharmaceutical Co Ltd

02 Dec 2025
LAST:

22.66

CHANGE:
 0.23
OPEN:
22.81
HIGH:
22.97
ASK:
0.00
VOLUME:
1.07M
CHG(%):
1.00
PREV:
22.89
LOW:
22.48
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
02 Dec 2522.8122.9722.4822.661.07M
01 Dec 2522.6523.2022.5122.891.83M
28 Nov 2522.6322.7622.3422.651.32M
27 Nov 2522.5022.8322.2922.631.64M
26 Nov 2522.2022.9322.0922.522.39M
25 Nov 2522.0822.3221.9522.001.68M
24 Nov 2522.0222.2021.9021.991.42M
21 Nov 2522.4822.5821.9621.992.13M
20 Nov 2522.5622.7922.3222.411.58M
19 Nov 2522.8823.0822.4522.591.61M

PROFILE

Name:Aurisco Pharmaceutical Co Ltd
About:Aurisco Pharmaceutical Co.,Ltd. engages in research, manufacturing, and marketing of pharmaceutical intermediates, specialty active pharmaceutical ingredients (API's), and formulations catering to the pharmaceutical market worldwide. The company offers APIs and intermediates of respiratory system, cardiovascular, anti-infection, nervous system, anti-tumor, and women's health drugs. It also provides dexamethasone is used to treat skin diseases; fluticasone propionate preparations are used to treat asthma and allergic rhinitis; fluticasone furoate preparations are used to treat asthma, allergic rhinitis, and chronic obstructive pulmonary disease; eplerenone preparations are used for the treatment of hypertension and heart failure; bepedalic acid preparations are used for the treatment of hypercholesterolemia or atherosclerotic cardiovascular diseases; tenofovir used for the treatment of HIV-1 infection and chronic hepatitis B; pregabalin preparations are used to treat neuropathic pain, fibromyalgia, epilepsy, etc.; brivaracetam preparations are used to treat epilepsy; abiraterone acetate preparation for the treatment of prostate cancer; enzalutamide preparation for the treatment of prostate cancer; and dydrogesterone preparations are used to treat dysmenorrhea, endometriosis, irregular menstrual cycle, etc. In addition, the company provides contract manufacturing services and related development works for chemicals, intermediates, and API's. Aurisco Pharmaceutical Co.,Ltd. was founded in 1998 and is headquartered in Tiantai, China.
Sector:Healthcare
Industry:Biotechnology
Address:Badu Industrial Park Zone, Tiantai, China, 317200
Website:https://www.aurisco.com
ISIN:CNE1000042S4

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:22.12 
Forward P/E:18.46 
PEG Ratio:18.46 
Price to Sales:5.86 
Price to Book:3.78 
Profit Margin:0.26 
Operating Margin:0.36 
Return on Assets:0.08 
Return on Equity:0.18 
DivYield:0.01 
Div/Share:0.29 
Revenue:1.624B 
EBITDA:506.46M 
Shares:406.2M 
Market Cap:9.204B 

TECHNICAL INDICATORS

MA5:22.670.0%
MA10:22.431.0%
MA20:22.760.5%
MA50:22.640.1%
MA100:22.881.0%
MA200:21.883.6%
STO9:55.37
STO14:35.08
RSI14:38.03 
WPR14:-56.21
MTM14:-0.68
ROC14:-0.03 
ATR:0.55 
Week High:23.202.4%
Week Low:21.953.2%
Month High:24.206.8%
Month Low:21.903.6%
Year High:26.3316.2%
Year Low:18.7021.2%

RECENT DIVIDENDS

Date Amount
20 Jun 2025$0.29
06 Jun 2024$0.22
22 May 2023$0.16
06 Jun 2022$0.13